Comparative analysis of the clinical efficacy of conservative treatment for adenomyosis using traditional Chinese medicine and Western medicine

Table 2 Relevant clinical indicators

Indicator	Time	Group A (n = 70)	Group B (n = 70)	Group C (n = 70)	F _time /P _time value	F _interaction/P _interaction value	F _treatment/P _treatment value
Uterus Volume	Pre-treatment ^a	146.08 ± 5.35	146.60 ± 3.39	147.03 ± 2.12	10775.137 /<0.001	1094.561 /<0.001	3588.864 /<0.001
	3 months of treatment ^b	76.15 ± 3.96	114.08 ± 4.81	133.74 ± 3.47
	6 months of treatment ^b	70.05 ± 2.88	106.53 ± 3.67	98.14 ± 4.37
Pelvic Pain (VAS)	Pre-treatment ^a	4.74 ± 1.37	4.61 ± 1.21	4.39 ± 1.17	240.624 /<0.001	9.859 /<0.001	25.389 /<0.001
	3 months of treatment ^b	2.57 ± 0.75	3.40 ± 0.81	3.04 ± 0.89
	6 months of treatment ^b	2.11 ± 0.50	3.31 ± 1.19	2.31 ± 0.55
PBAC	Pre-treatment ^a	99.20 ± 8.16	100.15 ± 10.63	101.73 ± 14.03	2368.378 /<0.001	136.452 /<0.001	320.101 /<0.001
	3 months of treatment ^b	68.51 ± 6.83	71.35 ± 9.52	39.43 ± 7.84
	6 months of treatment ^b	58.75 ± 10.01	28.46 ± 8.42	20.82 ± 6.85

Note: VAS: Visual Analogue Scale, PBAC: Menstrual volume, a: Without significant differences between groups, b: With significant differences between groups

ISSN: 2072-1315